Medifast (NYSE:MED) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $(0.65) by 56.92 percent. This is a 227.27 percent decrease over earnings of $0.22 per share from the same period last year. The company reported quarterly sales of $76.384 million which beat the analyst consensus estimate of $72.700 million by 5.07 percent. This is a 27.67 percent decrease over sales of $105.600 million the same period last year.